PATENT CLAIM ANALYSIS

Application Number: 15773512
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "189100"]

Abstract:
The present application provides immunotherapies for Hepatitis B virus infections. Provided herein are genetically modified arenaviral vectors suitable as vaccines for prevention and treatment of Hepatitis B virus infections. Also provided herein are pharmaceutical compositions and methods for the treatment of Hepatitis B virus infections. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of treating Hepatitis B virus infection.

Claim (Index 37):
The pharmaceutical composition of  claim 33  or  34 , wherein the first nucleic acid sequence encodes the HBV HBc protein or fragment thereof, and wherein the second nucleic acid sequence encodes the fusion of the HBV HBs and HBc proteins or fragments thereof.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 93.0
- Lexical Diversity: 1.91429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15101363', '15580964', '14775484', '13037931', '12810382']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7826021849023683
- 35 USC 102 Novelty (BERT): 0.5523342215751422
- Combined Prediction Score: 0.7595753885696458
- Mean Citation Score: 372.36386
- Max Citation Score: 449.82828
- Similarity Product: 289.4179931250286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test